NCT01577459View on ClinicalTrials.gov

A Phase 1 Crossover Study of Blood Pressure and Heart Rate Response

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

April 23, 2012

Primary Completion Date

June 15, 2012

Study Completion Date

June 15, 2012

Conditions
Healthy Subjects
Interventions
DRUG

TR-701 FA with PSE

TR-701 FA Oral 200 mg oral with PSE

OTHER

TR-701 FA Placebo with PSE

TR-701 FA Placebo Oral 200 mg with PSE

Trial Locations (1)

66212

Trius Investigator Site 001, Overland Park

All Listed Sponsors
lead

Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

INDUSTRY

NCT01577459 - A Phase 1 Crossover Study of Blood Pressure and Heart Rate Response | Biotech Hunter | Biotech Hunter